Volume 1 Issue 1 2022 – Acta Pharma Reports

Safety and Efficacy of Khamira Gawzaban Sada (KGS) in Mild Cognitive Impairment: A Pilot Open-Label Clinical Trial

Humaira Bano¹
Nikhat Shaikh²
Shah Alam²
Arjumand Shah³
Mohammed Sheeraz⁴
Irfan Ahmed²
MD Manzar Alam⁵

1. Introduction Mild cognitive impairment (MCI) is characterized by objective cognitive decline exceeding that expected for age and education, without sufficient severity to impair activities of daily living. Epidemiological data project a global prevalence of MCI approaching 15–20% in adults over 65 years [1]. Critically, approximately 10–15% of MCI cases convert to Alzheimer’s disease annually, … Read more

Predicting The Outcomes Of Achilles Tenotomy For Children Treated With The Ponseti Method For Congenital Talipes Equinovarus

Evaluation Of Silver Nanogel Loaded With Micronised Activated Charcoal For Wound Healing Applications

Cross-Sectional Study Of The Association Between Obesity And Subclinical Hypothyroidism

Efficacy Of Cranberry Hydrogel In Reduction Of Candida And P. Gingivalis In Peri Implantitis

Evaluation Of Pain Perception During Micro-Osteoperforation Assisted Maxillary En-Masse Retraction: A Randomized Controlled Trial

Introducing Acta Pharma Reports: A Beacon for Transparent Journal Publication

Huda Nafees¹

In the dynamic landscape of scientific research, the importance of transparent, reliable, and accessible publication avenues cannot be overstated. With the burgeoning complexities in pharmaceutical and medical research, there arises an urgent need for a scholarly platform that not only upholds rigorous scientific standards but also fosters collaboration, innovation, and trust within the scientific community … Read more